Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Strata Skin Sciences Debt to Equity Ratio 2010-2025 | SSKN

Current and historical debt to equity ratio values for Strata Skin Sciences (SSKN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Strata Skin Sciences debt/equity for the three months ending March 31, 2025 was 5.71.
  
Strata Skin Sciences Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $0.03B $0.00B 11.84
2024-12-31 $0.03B $0.01B 6.27
2024-09-30 $0.03B $0.01B 3.30
2024-06-30 $0.03B $0.01B 3.17
2024-03-31 $0.03B $0.01B 3.25
2023-12-31 $0.03B $0.01B 2.31
2023-09-30 $0.03B $0.02B 1.91
2023-06-30 $0.04B $0.02B 2.27
2023-03-31 $0.03B $0.02B 1.54
2022-12-31 $0.03B $0.02B 1.39
2022-09-30 $0.03B $0.02B 1.44
2022-06-30 $0.03B $0.02B 1.40
2022-03-31 $0.03B $0.02B 1.32
2021-12-31 $0.02B $0.03B 0.83
2021-09-30 $0.02B $0.03B 0.79
2021-06-30 $0.02B $0.03B 0.74
2021-03-31 $0.02B $0.02B 0.90
2020-12-31 $0.02B $0.03B 0.81
2020-09-30 $0.02B $0.03B 0.82
2020-06-30 $0.02B $0.03B 0.73
2020-03-31 $0.02B $0.03B 0.64
2019-12-31 $0.02B $0.03B 0.65
2019-09-30 $0.02B $0.03B 0.65
2019-06-30 $0.02B $0.03B 0.63
2019-03-31 $0.02B $0.03B 0.58
2018-12-31 $0.02B $0.03B 0.52
2018-09-30 $0.01B $0.03B 0.38
2018-06-30 $0.01B $0.03B 0.37
2018-03-31 $0.02B $0.02B 0.86
2017-12-31 $0.02B $0.02B 0.97
2017-09-30 $0.02B $0.02B 0.67
2017-06-30 $0.03B $0.01B 2.69
2017-03-31 $0.03B $0.01B 2.43
2016-12-31 $0.03B $0.02B 1.94
2016-09-30 $0.03B $0.02B 1.71
2016-06-30 $0.03B $0.02B 1.57
2016-03-31 $0.03B $0.02B 2.16
2015-12-31 $0.03B $0.02B 2.11
2015-09-30 $0.04B $0.02B 2.29
2015-06-30 $0.03B $0.03B 1.00
2015-03-31 $0.01B $0.01B 1.15
2014-12-31 $0.01B $0.01B 0.64
2014-09-30 $0.01B $0.02B 0.60
2014-06-30 $0.01B $0.01B 0.75
2014-03-31 $0.01B $0.01B 1.73
2013-12-31 $0.01B $0.01B 0.70
2013-09-30 $0.00B $0.01B 0.28
2013-06-30 $0.01B $0.02B 0.52
2013-03-31 $0.01B $0.02B 0.36
2012-12-31 $0.00B $0.01B 0.24
2012-09-30 $0.00B $0.02B 0.15
2012-06-30 $0.00B $0.02B 0.13
2012-03-31 $0.00B $0.02B 0.07
2011-12-31 $0.00B $0.03B 0.05
2011-09-30 $0.00B $0.02B 0.08
2011-06-30 $0.00B $0.02B 0.06
2011-03-31 $0.00B $0.03B 0.07
2010-12-31 $0.00B $0.03B 0.06
2010-09-30 $0.00B $0.04B 0.05
2010-06-30 $0.00B $0.03B 0.07
2010-03-31 $0.00B $0.03B 0.05
2009-12-31 $0.00B $0.03B 0.06
2009-09-30 $0.00B $0.03B 0.06
2009-06-30 $0.00B $0.01B 0.18
2009-03-31 $0.00B $0.01B 0.13
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.009B $0.034B
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.172B 58.74
Hims & Hers Health (HIMS) United States $12.418B 129.02
Tempus AI (TEM) United States $12.340B 0.00
IRhythm Technologies (IRTC) United States $4.592B 0.00
Inspire Medical Systems (INSP) United States $3.751B 58.61
Privia Health (PRVA) United States $2.761B 188.75
Hinge Health (HNGE) United States $2.719B 0.00
Enovis (ENOV) United States $1.822B 10.16
Schrodinger (SDGR) United States $1.572B 0.00
Phreesia (PHR) United States $1.547B 0.00
Clover Health Investments (CLOV) United States $1.468B 0.00
Azenta (AZTA) United States $1.401B 65.11
Omnicell (OMCL) United States $1.370B 24.17
10x Genomics (TXG) United States $1.282B 0.00
Fulgent Genetics (FLGT) United States $0.630B 0.00
Claritev (CTEV) United States $0.610B 0.00
Butterfly Network (BFLY) United States $0.569B 0.00
Veradigm (MDRX) United States $0.487B 0.00
Talkspace (TALK) United States $0.477B 142.50
Standard BioTools (LAB) United States $0.399B 0.00
Outset Medical (OM) United States $0.354B 0.00
TruBridge (TBRG) United States $0.347B 769.00
Health Catalyst (HCAT) United States $0.264B 0.00
Nyxoah SA (NYXH) Belgium $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.149B 0.00
EUDA Health Holdings (EUDA) Singapore $0.138B 0.00
Pulmonx (LUNG) United States $0.122B 0.00
American Well (AMWL) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.095B 0.00
CareCloud (CCLD) United States $0.088B 3.34
111 (YI) China $0.070B 0.00
HeartBeam (BEAT) United States $0.051B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
Zepp Health (ZEPP) Netherlands $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00